ABL Bio

ABL Bio is a Seoul-based biotechnology company that functions as a strategic corporate investor in life sciences. The firm has acted as a lead investor in a U.S. Series A financing and is relevant for early-stage biotechnology, oncology, pharmaceuticals and broader life sciences companies, particularly where antibody therapeutics or cancer drug development are strategically aligned.